ASX - By Stock
|
MYX |
Re:
Ann: NEXTSTELLIS FDA exclusivity & phase III data published
|
|
osha005
|
37 |
18K |
1 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
37
|
18K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: NEXTSTELLIS FDA exclusivity & phase III data published
|
|
osha005
|
37 |
18K |
3 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
37
|
18K
|
3
|
|
ASX - By Stock
|
OSL |
The London Clinic
|
|
osha005
|
3 |
2.3K |
12 |
24/03/21 |
24/03/21 |
ASX - By Stock
|
3
|
2.3K
|
12
|
|
NZX - By Stock
|
AFT |
Re:
Ann: GENERAL: AFT: Maxigesic(R) IV licensed in eight new European markets
|
|
osha005
|
2 |
976 |
1 |
05/03/21 |
05/03/21 |
NZX - By Stock
|
2
|
976
|
1
|
|
ASX - By Stock
|
MYX |
Re:
What to expect next year?
|
|
osha005
|
198 |
108K |
9 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
198
|
108K
|
9
|
|
ASX - By Stock
|
OSL |
Media
|
|
osha005
|
18 |
13K |
16 |
20/12/20 |
20/12/20 |
ASX - By Stock
|
18
|
13K
|
16
|
|